Travaux scientifiques
Doç. Dr. Pınar Tığlıoğlu
34 publications. La source de l’information est indiquée à côté de chaque publication.
-
Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study
Leukemia Research, 2026
DOI 10.1016/j.leukres.2026.108342 PMID 42933070 Source : OpenAlex
-
Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL
Annals of Hematology, 2026
DOI 10.1007/s00277-026-07201-y PMID 42897372 Texte intégral en libre accèsSource : ORCID
-
Publication Only
HemaSphere, 2026
DOI 10.1002/hem3.70421 Texte intégral en libre accèsSource : OpenAlex
-
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14207294 PMID 41156164 Texte intégral en libre accèsSource : OpenAlex
-
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14196813 PMID 41095893 Texte intégral en libre accèsSource : OpenAlex
-
Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients
Annals of Hematology, 2025
DOI 10.1007/s00277-025-06644-z PMID 41074982 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Immunological biomarkers and TARC/CCL17 in myelodysplastic syndrome: Insights into immune microenvironment regulation
Blood, 2025
DOI 10.1182/blood-2025-7359 Texte intégral en libre accèsSource : OpenAlex
-
CURRENT TREATMENT METHODS FOR EARLY RELAPSED MULTIPLE MYELOMA
Turkiye Klinikleri eBooks, 2025
DOI 10.5336/978-625-395-694-3_p55 Source : OpenAlex
-
A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study
Medicine, 2024
DOI 10.1097/md.0000000000037802 PMID 38608056 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Change in Hepatitis B Surface Antibody Titers After Chemotherapy in Patients With Hematological Malignancies
Cureus, 2024
DOI 10.7759/cureus.51572 PMID 38314000 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
The Prognostic Impact of Comorbidity, Nutritional and Performance Status on Patients with Diffuse Large B Cell Lymphoma
Nigerian Journal of Clinical Practice, 2023
DOI 10.4103/njcp.njcp_175_23 PMID 37929528 6 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience
Journal of Hematopathology, 2022
DOI 10.1007/s12308-022-00488-6 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Marjinal Zon Lenfoma Tanılı Hastalarda Klinik Özellikler ve Olası Prognostik Faktörler: İki Merkezden Retrospektif Analiz
LLM Dergi, 2022
DOI 10.5578/llm.20229903 Texte intégral en libre accèsSource : OpenAlex
-
Analysis of Demographic and Disease Characteristics of Patients with Chronic Myeloid Leukemia: A Single Centre Retrospective Analysis
Acta Oncologica Turcica, 2022
DOI 10.5505/aot.2022.08831 Texte intégral en libre accèsSource : OpenAlex
-
Single Centre Experience: Bening and Malign Hematological Patients with COVID-19
Sağlık Akademisi Kastamonu, 2022
DOI 10.25279/sak.1061701 Texte intégral en libre accèsSource : OpenAlex
-
Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect
Journal of Clinical Pharmacy and Therapeutics, 2022
DOI 10.1111/jcpt.13512 PMID 34423448 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Analysis of factors predicting the efficacy of Imatinib in patients with Chronic Myeloid Leukemia: A retrospective analysis
Medical Science and Discovery, 2022
DOI 10.36472/msd.v9i9.802 Texte intégral en libre accèsSource : OpenAlex
-
RELAPSED MANTLE CELL LYMPHOMA WITH ISOLATED CENTRAL NERVOUS SYSTEM INVOLVEMENT THAT TREATED WITH IBRUTINIB; A CASE REPORT AND LITERATURE REVIEW
Hematology Transfusion and Cell Therapy, 2022
DOI 10.1016/j.htct.2022.09.1247 Texte intégral en libre accèsSource : OpenAlex
-
Bir Pandeminin Anatomisi COVID-19
Akademisyen Kitabevi eBooks, 2022
DOI 10.37609/akya.1788 Texte intégral en libre accèsSource : OpenAlex
-
The outcome of COVID-19 in patients with hematological malignancy
memo - Magazine of European Medical Oncology, 2021
DOI 10.1007/s12254-021-00775-5 PMID 34904019 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment
Journal of Oncology Pharmacy Practice, 2021
DOI 10.1177/10781552211060730 PMID 34775854 3 citations (Europe PMC) Source : OpenAlex
-
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1057 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1033 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1039 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1034 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
A RARE AND COMPLEX CAUSE OF IMPOTENCE POEMS SYNDROME
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1045 Texte intégral en libre accèsSource : OpenAlex
-
CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1030 Texte intégral en libre accèsSource : OpenAlex
-
A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1064 Texte intégral en libre accèsSource : OpenAlex
-
T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1019 Texte intégral en libre accèsSource : OpenAlex
-
A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1060 Texte intégral en libre accèsSource : OpenAlex
-
ANTI-CD52 TREATMENT EXPERIENCE IN A T-CELL PROLYMPHOCYTIC LEUKEMIA PATIENT:CASE REPORT
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1014 Texte intégral en libre accèsSource : OpenAlex
-
INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1018 Texte intégral en libre accèsSource : OpenAlex
-
A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT
Hematology Transfusion and Cell Therapy, 2021
DOI 10.1016/j.htct.2021.10.1037 Texte intégral en libre accèsSource : OpenAlex
-
COVID-19 ve Kanser
Akademisyen Kitabevi eBooks, 2021
DOI 10.37609/akya.668 Source : ORCID